
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : LCTG-001
Therapeutic Area : Immunology
Study Phase : Preclinical
Sponsor : Lactiga
Deal Size : Undisclosed
Deal Type : Collaboration
Kenox Partners with Lactiga to Advance Mucosal-Targeted Immunotherapy
Details : The collaboration will leverage Kenox extensive expertise in nasal and inhaled pharmaceutical development of LCTG-001. It is being evaluated for mucosal-targeted Secretory IgA.
Product Name : Undisclosed
Product Type : Antibody, Unconjugated
Upfront Cash : Undisclosed
March 10, 2025
Lead Product(s) : LCTG-001
Therapeutic Area : Immunology
Highest Development Status : Preclinical
Sponsor : Lactiga
Deal Size : Undisclosed
Deal Type : Collaboration
